Three subjects had preinfusion and postinfusion tumor tissue analyzed for markers of immune activation (CD3, CD4, CD8), regulatory T cell function (Foxp3) and tumor cell proliferation (Ki67, pS6; Table 5). The gene discussed is CD8A; the disease is neoplasm.